A detailed history of Public Employees Retirement Association Of Colorado transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Public Employees Retirement Association Of Colorado holds 173,255 shares of GILD stock, worth $15.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
173,255
Previous 173,279 0.01%
Holding current value
$15.7 Million
Previous $11.9 Million 22.18%
% of portfolio
0.06%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$66.59 - $83.99 $1,598 - $2,015
-24 Reduced 0.01%
173,255 $14.5 Million
Q2 2024

Aug 12, 2024

SELL
$63.15 - $72.88 $310,066 - $357,840
-4,910 Reduced 2.76%
173,279 $11.9 Million
Q1 2024

May 15, 2024

SELL
$71.58 - $87.29 $516,950 - $630,408
-7,222 Reduced 3.9%
178,189 $13.1 Million
Q4 2023

Feb 13, 2024

SELL
$73.27 - $83.09 $382,396 - $433,646
-5,219 Reduced 2.74%
185,411 $15 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $13.6 Million - $14.9 Million
184,419 Added 2969.23%
190,630 $14.3 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $14.4 Million - $15.7 Million
-194,821 Reduced 96.91%
6,211 $419,000
Q2 2023

Aug 09, 2023

SELL
$76.01 - $86.7 $393,655 - $449,019
-5,179 Reduced 2.51%
201,032 $15.5 Million
Q1 2023

May 08, 2023

SELL
$77.31 - $88.08 $483,187 - $550,500
-6,250 Reduced 2.94%
206,211 $17.1 Million
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $529,657 - $760,405
8,499 Added 4.17%
212,461 $18.2 Million
Q3 2022

Nov 15, 2022

SELL
$59.54 - $68.01 $11,133 - $12,717
-187 Reduced 0.09%
203,962 $12.6 Million
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $53,910 - $60,719
-934 Reduced 0.46%
204,149 $12.6 Million
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $803,292 - $1.01 Million
-13,869 Reduced 6.33%
205,083 $12.2 Million
Q4 2021

Feb 11, 2022

SELL
$64.88 - $73.64 $249,528 - $283,219
-3,846 Reduced 1.73%
218,952 $15.9 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $33,641 - $36,295
-497 Reduced 0.22%
222,798 $15.6 Million
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $28,498 - $31,138
-449 Reduced 0.2%
223,295 $15.4 Million
Q1 2021

May 13, 2021

SELL
$60.0 - $68.46 $85,080 - $97,076
-1,418 Reduced 0.63%
223,744 $14.5 Million
Q4 2020

Feb 11, 2021

SELL
$56.65 - $64.55 $633,856 - $722,249
-11,189 Reduced 4.73%
225,162 $13.1 Million
Q3 2020

Nov 09, 2020

SELL
$62.1 - $78.08 $56,138 - $70,584
-904 Reduced 0.38%
236,351 $14.9 Million
Q2 2020

Aug 05, 2020

SELL
$72.34 - $84.0 $209,786 - $243,600
-2,900 Reduced 1.21%
237,255 $18.3 Million
Q1 2020

May 01, 2020

BUY
$62.63 - $80.22 $407,721 - $522,232
6,510 Added 2.79%
240,155 $18 Million
Q4 2019

Feb 05, 2020

SELL
$61.62 - $67.78 $14,480 - $15,928
-235 Reduced 0.1%
233,645 $15.2 Million
Q3 2019

Nov 05, 2019

SELL
$62.51 - $69.0 $47,882 - $52,854
-766 Reduced 0.33%
233,880 $14.8 Million
Q2 2019

Jul 31, 2019

SELL
$61.87 - $69.38 $573,844 - $643,499
-9,275 Reduced 3.8%
234,646 $15.9 Million
Q1 2019

Apr 30, 2019

BUY
$62.53 - $70.05 $694,458 - $777,975
11,106 Added 4.77%
243,921 $15.9 Million
Q4 2018

Feb 08, 2019

SELL
$60.54 - $79.0 $33,054 - $43,134
-546 Reduced 0.23%
232,815 $14.6 Million
Q3 2018

Oct 29, 2018

SELL
$71.28 - $78.92 $17,321 - $19,177
-243 Reduced 0.1%
233,361 $18 Million
Q2 2018

Aug 02, 2018

SELL
$64.88 - $75.68 $33.4 Million - $39 Million
-515,335 Reduced 68.81%
233,604 $16.5 Million
Q1 2018

May 01, 2018

SELL
$72.84 - $88.8 $1.99 Million - $2.43 Million
-27,331 Reduced 3.52%
748,939 $56.5 Million
Q4 2017

Feb 02, 2018

BUY
$71.15 - $83.52 $2.85 Million - $3.34 Million
40,049 Added 5.44%
776,270 $55.6 Million
Q3 2017

Oct 30, 2017

BUY
$72.11 - $85.47 $53.1 Million - $62.9 Million
736,221
736,221 $59.6 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.